MediPal Holdings Past Earnings Performance
Past criteria checks 2/6
MediPal Holdings has been growing earnings at an average annual rate of 3.3%, while the Healthcare industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 2.1% per year. MediPal Holdings's return on equity is 6.7%, and it has net margins of 1.1%.
Key information
3.3%
Earnings growth rate
4.1%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 2.1% |
| Return on equity | 6.7% |
| Net Margin | 1.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
MediPal Holdings (TSE:7459) Has Announced A Dividend Of ¥30.00
Aug 06
MediPal Holdings Corporation (TSE:7459) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 05Returns On Capital At MediPal Holdings (TSE:7459) Have Hit The Brakes
Jun 25Concerns Surrounding MediPal Holdings' (TSE:7459) Performance
May 22Some Confidence Is Lacking In MediPal Holdings Corporation's (TSE:7459) P/E
May 08Revenue & Expenses Breakdown
How MediPal Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 3,581,312 | 39,294 | 188,012 | 0 |
| 31 Mar 24 | 3,558,732 | 41,474 | 185,677 | 0 |
| 31 Dec 23 | 3,507,505 | 37,244 | 178,360 | 0 |
| 30 Sep 23 | 3,453,601 | 38,636 | 177,341 | 0 |
| 30 Jun 23 | 3,408,417 | 41,724 | 167,292 | 0 |
| 31 Mar 23 | 3,360,008 | 38,806 | 163,143 | 0 |
| 31 Dec 22 | 3,351,069 | 30,439 | 165,230 | 0 |
| 30 Sep 22 | 3,333,073 | 28,222 | 161,021 | 0 |
| 30 Jun 22 | 3,304,372 | 28,248 | 160,279 | 0 |
| 31 Mar 22 | 3,290,921 | 29,423 | 159,487 | 0 |
| 31 Dec 21 | 3,279,583 | 36,411 | 158,300 | 0 |
| 30 Sep 21 | 3,265,951 | 30,523 | 158,634 | 0 |
| 30 Jun 21 | 3,241,838 | 26,468 | 160,995 | 0 |
| 31 Mar 21 | 3,211,125 | 23,926 | 162,908 | 0 |
| 31 Dec 20 | 3,208,237 | 26,682 | 166,875 | 0 |
| 30 Sep 20 | 3,186,651 | 33,329 | 168,472 | 0 |
| 30 Jun 20 | 3,236,315 | 37,002 | 169,743 | 0 |
| 31 Mar 20 | 3,253,079 | 37,968 | 171,135 | 0 |
| 31 Dec 19 | 3,242,840 | 34,722 | 170,226 | 0 |
| 30 Sep 19 | 3,253,495 | 35,443 | 170,753 | 0 |
| 30 Jun 19 | 3,189,613 | 34,116 | 170,788 | 0 |
| 31 Mar 19 | 3,181,928 | 34,359 | 171,152 | 0 |
| 31 Dec 18 | 3,178,578 | 34,315 | 171,101 | 0 |
| 30 Sep 18 | 3,169,344 | 34,122 | 171,498 | 0 |
| 30 Jun 18 | 3,169,216 | 37,166 | 170,446 | 0 |
| 31 Mar 18 | 3,146,314 | 34,780 | 170,582 | 0 |
| 31 Dec 17 | 3,124,724 | 33,199 | 170,518 | 0 |
| 30 Sep 17 | 3,093,743 | 31,086 | 169,517 | 0 |
| 30 Jun 17 | 3,072,597 | 26,239 | 169,038 | 0 |
| 31 Mar 17 | 3,063,900 | 29,011 | 167,853 | 0 |
| 31 Dec 16 | 3,065,833 | 32,149 | 168,960 | 0 |
| 30 Sep 16 | 3,072,868 | 32,201 | 167,879 | 0 |
| 30 Jun 16 | 3,057,501 | 33,965 | 166,292 | 0 |
| 31 Mar 16 | 3,028,187 | 30,771 | 164,574 | 0 |
| 31 Dec 15 | 2,995,210 | 28,449 | 159,818 | 0 |
| 30 Sep 15 | 2,953,707 | 26,052 | 158,598 | 0 |
| 30 Jun 15 | 2,923,061 | 23,938 | 157,962 | 0 |
| 31 Mar 15 | 2,872,905 | 23,687 | 158,348 | 0 |
| 31 Dec 14 | 2,902,889 | 22,221 | 160,875 | 0 |
| 30 Sep 14 | 2,909,858 | 21,592 | 161,971 | 0 |
| 30 Jun 14 | 2,920,808 | 22,231 | 162,876 | 0 |
| 31 Mar 14 | 2,947,798 | 25,485 | 163,175 | 0 |
| 31 Dec 13 | 2,883,615 | 23,157 | 172,996 | 0 |
| 30 Sep 13 | 2,860,467 | 19,380 | 173,465 | 0 |
Quality Earnings: 7459 has high quality earnings.
Growing Profit Margin: 7459's current net profit margins (1.1%) are lower than last year (1.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7459's earnings have grown by 3.3% per year over the past 5 years.
Accelerating Growth: 7459's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 7459 had negative earnings growth (-5.8%) over the past year, making it difficult to compare to the Healthcare industry average (9.8%).
Return on Equity
High ROE: 7459's Return on Equity (6.7%) is considered low.